Results 21 to 30 of about 46,868 (196)

Methodological Study of Reliability Test of Percutaneous Ventricular Assist Device

Zhongguo yiliao qixie zazhi
Prior to clinical application, reliability of percutaneous ventricular assist devices(pVAD) requires to be tested systematically. Currently, there's a lack of dedicated reliability testing equipment and methodologies for pVAD.
Xun LIU, Da ZHU, Yujing ZHANG, Xiangbin PAN   +3 more
doaj   +1 more source

Use of Right Ventricular Assist Device Post-Left Ventricular Assist Device Placement

Hearts
Right heart failure (RHF) is a common manifestation after left ventricular assist device (LVAD) placement and is associated with a high mortality rate. Historically, RV failure requiring an RVAD at the time of LVAD implantation has been associated with ...
Shannon Parness, Tori E. Hester, Harish Pandyaram, Panagiotis Tasoudis, Aurelie E. Merlo   +4 more
doaj   +1 more source

Targeted myocardial gene expression in failing hearts by RNA sequencing

Journal of Translational Medicine, 2016
Background Myocardial recovery with left ventricular assist device (LVAD) therapy is highly variable and difficult to predict. Next generation ribonucleic acid (RNA) sequencing is an innovative, rapid, and quantitative approach to gene expression ...
Kajari Dhar, Alexandra M. Moulton, Eric Rome, Fang Qiu, Jeff Kittrell, Eugenia Raichlin, Ronald Zolty, John Y. Um, Michael J. Moulton, Hesham Basma, Daniel R. Anderson, James D. Eudy, Brian D. Lowes   +12 more
doaj   +1 more source

Hybrid closure of ventricular septal defect and implantation of systemic right ventricular assist device

ESC Heart Failure, 2022
A 50‐year‐old female patient was readmitted with refractory systemic right ventricular failure. The patient underwent a Mustard procedure during childhood for transposition of the great arteries.
Jerome Soquet, Ali Houeijeh, Marjorie Richardson, Eleonore Hebbar, Guy Vaksmann, Jean‐Benoit Baudelet, Mouhamed Djahoum Moussa, Andre Vincentelli   +7 more
doaj   +1 more source

Ventricular assist devices

Continuing Education in Anaesthesia Critical Care & Pain, 2012
Heart failure occurs in 1% of the UK adult population yet represents 5% of all hospital admissions, according to the 2008/09 National Heart Failure audit (http://www.ic.nhs.uk/ webfiles/publications/002_Audits/NHS_IC_ HEART_FAILURE_AUDIT_13-12-10.pdf ).
Paul Harris, Lakshminarasimhan Kuppurao
openaire   +2 more sources

Successful bridge to recovery in fulminant myocarditis using a biventricular assist device: a case report

Journal of Medical Case Reports, 2017
Background Fulminant myocarditis is a life-threatening disease, and myocardial damage expands the right ventricle as well as the left ventricle in some cases.
Yusuke Adachi, Osamu Kinoshita, Masaru Hatano, Yukako Shintani, Noritsugu Naito, Mitsutoshi Kimura, Kan Nawata, Daisuke Nitta, Hisataka Maki, Kazutaka Ueda, Eisuke Amiya, Eiki Takimoto, Issei Komuro, Minoru Ono   +13 more
doaj   +1 more source

Design and characteristics of the prophylactic intra‐operative ventricular arrhythmia ablation in high‐risk LVAD candidates (PIVATAL) trial

Annals of Noninvasive Electrocardiology, 2023
Background The use of a Left Ventricular Assist Device (LVAD) in patients with advanced heart failure refractory to optimal medical management has progressed steadily over the past two decades. Data have demonstrated reduced LVAD efficacy, worse clinical
David T. Huang, Igor Gosev, Katherine L. Wood, Hima Vidula, William Stevenson, Frank Marchlinski, Gregory Supple, Sandip K. Zalawadiya, J. Peter Weiss, Roderick Tung, Wendy S. Tzou, Joshua D. Moss, Krishna Kancharla, Sunit‐Preet Chaudhry, Parin J. Patel, Arfaat M. Khan, Claudio Schuger, Guy Rozen, Michael S. Kiernan, Gregory S. Couper, Marzia Leacche, Ezequiel J. Molina, Anand D. Shah, Michael Lloyd, Jakub Sroubek, Edward Soltesz, Kalyanam Shivkumar, Casey White, Sinan Tankut, Brent A. Johnson, Scott McNitt, Valentina Kutyifa, Wojciech Zareba, Ilan Goldenberg   +33 more
doaj   +1 more source

Experience with left ventricular assist device usage in the treatment of end-stage heart failure [PDF]

Кардіохірургія та інтервенційна кардіологія, 2017
Heart failure potentially developing in most of heart diseases is a progressive process associated with high morbidity and mortality. Almost 3/4 of patients die within five years after first hospitalization because of heart failure.
B.M. Todurov, G.I. Kovtun, I.M. Kuzmich, M.V. Goncharenko, A.M. Druzhyna, A.O. Shpachuk, O.M. Postupalsky, S.O. Sheludko, S.M. Sudakevych, O.V. Stanyshevskyi, A.Yu. Melnyk   +10 more
doaj  

Ethical challenges with the left ventricular assist device as a destination therapy

Philosophy, Ethics, and Humanities in Medicine, 2008
The left ventricular assist device was originally designed to be surgically implanted as a bridge to transplantation for patients with chronic end-stage heart failure.
Rady Mohamed Y, Verheijde Joseph L, Rizzieri Aaron G, McGregor Joan L   +3 more
doaj   +1 more source

Case report: Facilitating right heart recovery after durable LVAD implantation through repair of atrioventricular valves and RVAD implantation using tunneled Dacron grafts

Frontiers in Cardiovascular Medicine, 2023
Right ventricular assist device (RVAD) weaning is often an important goal for durable left ventricular assist device support. This may be facilitated by mitral and tricuspid repair as well as by minimizing the trauma of RVAD decannulation by using Dacron
K. Candis Jones-Ungerleider, Syed Sikandar Raza, Paul C. Tang, Paul C. Tang   +3 more
doaj   +1 more source